PPFIBP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.537400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.223800E-01
Normal-vs-Stage2
8.744800E-01
Normal-vs-Stage3
7.304600E-01
Normal-vs-Stage4
4.488600E-01
Stage1-vs-Stage2
3.869700E-02
Stage1-vs-Stage3
9.814000E-01
Stage1-vs-Stage4
2.670400E-01
Stage2-vs-Stage3
4.648400E-01
Stage2-vs-Stage4
1.763230E-01
Stage3-vs-Stage4
3.110400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.551000E-01
Normal-vs-AfricanAmerican
9.339200E-01
Normal-vs-Asian
8.418400E-01
Caucasian-vs-AfricanAmerican
7.402200E-01
Caucasian-vs-Asian
6.309400E-01
AfricanAmerican-vs-Asian
8.287400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.760600E-01
Normal-vs-Female
8.559200E-01
Male-vs-Female
4.215800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.160800E-01
Normal-vs-Age(41-60Yrs)
6.361000E-01
Normal-vs-Age(61-80Yrs)
8.999200E-01
Normal-vs-Age(81-100Yrs)
9.026200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.459600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.704400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.431800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.461600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.704800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.796000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.820800E-01
Normal-vs-Daily Drinker
6.906000E-01
Normal-vs-Weekly Drinker
7.699200E-01
Normal-vs-Occasional Drinker
7.976200E-01
Normal-vs-Social Drinker
5.046600E-01
Non Drinker-vs-Daily Drinker
9.601400E-01
Non Drinker-vs-Weekly Drinker
1.172570E-01
Non Drinker-vs-Occasional Drinker
1.938560E-01
Non Drinker-vs-Social Drinker
4.737600E-02
Daily Drinker-vs-Weekly Drinker
2.283800E-01
Daily Drinker-vs-Occasional Drinker
2.261000E-01
Daily Drinker-vs-Social Drinker
4.834400E-02
Weekly Drinker-vs-Occasional Drinker
9.228400E-01
Weekly Drinker-vs-Social Drinker
3.595600E-01
Occasional Drinker-vs-Social Drinker
4.400000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.185600E-01
Normal-vs-Grade 2
6.108300E-02
Normal-vs-Grade 3
1.190200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.516000E-03
Grade 1-vs-Grade 3
2.435000E-04
Grade 1-vs-Grade 4
3.185600E-01
Grade 2-vs-Grade 3
6.065600E-02
Grade 2-vs-Grade 4
6.108300E-02
Grade 3-vs-Grade 4
1.190200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.043000E-01
Normal-vs-NonDiabetic
9.770200E-01
Diabetic-vs-NonDiabetic
6.246000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.253200E-01
Normal-vs-NoPancreatitis
9.887800E-01
Pancreatitis-vs-NoPancreatitis
8.876200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.141200E-01
Normal-vs-N1
8.718600E-01
N0-vs-N1
3.932600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.003400E-01
Normal-vs-TP53-NonMutant
7.220800E-01
TP53-Mutant-vs-TP53-NonMutant
5.395600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
